Abstract:INTRODUCTION AND OBJECTIVES: According to data from SEER (http://seer.cancer.gov/) in the United States, bladder cancer (BC) has improved 5-year survival rate by only 3% in the last two decades.D-3-phosphoglycerate dehydrogenase (PHGDH) is an enzyme that converts 3-phosphoglycerate on glycolysis system and induces metabolism to serine synthesis.Cancers require serine to maintain rapid, sustained and uncontrollable proliferation.Recently it has been reported that PHGDH can be a therapeutic target in breast cancer and melanoma, on the other hand there has been no report on BC.The aim of this study is to evaluate therapeutic possibility regarding PHGDH in BC.METHODS: Clinical significance of PHGDH in BC was analyzed using The Cancer Genome Atlas (TCGA) which is a public database.In addition, the effect of PHGDH inhibitor (NCT-503) and si-RNA against PHGDH was evaluated by cell proliferation and apoptosis assay in BC cell lines (T24, BOY, KK47, UMUC-3, J82).In xenograft assay, PHGDH knockdown efficiency was investigated using sh-RNA against PHGDH.Furthermore, additive effect of the PHGDH inhibitor under Gemcitabine and Cisplatin (GC) administration was examined.RESULTS: In the PHGDH high expression group (n [ 157), the prognosis was poor (P [ 0.0032) compared with the low expression group (n [ 247), and PHGDH was found to be an independent poor prognostic factor (P [ 0.001) in multivariate analysis.The PHGDH inhibitor and PHGDH si-RNAs significantly inhibited proliferative ability through induction of apoptosis (P < 0.05) in BC cell lines.Western blot analyses showed that Ki-67 expression was markedly repressed and cleaved caspase-3 expression was increased in PHGDH knockdown BC cells compared with those in control BC cells.Additionally, cells with PHGDH overexpression promoted tumor cell viability in comparison to control cells.In xenograft assay, PHGDH knockdown by sh-RNA significantly inhibited tumor progression compared to the vehicle group (P < 0.05).Furthermore, the combination treatment between PHGDH inhibitor and GC showed synergistic tumor suppressive effect compared to each single agent group (P < 0.05) in proliferation assay.CONCLUSIONS: Our study revealed that PHGDH inhibition showed tumor suppressive effects in BC.Furthermore, the combination therapy between PHGDH inhibitor and GC showed synergistic effect in proliferation assay.Novel therapeutic implications through functional analysis of PHGDH in BC were suggested.

Diallyl Disulfide Regulates Proliferation, Apoptosis and Aerobic Glycolysis by Down-Regulating PKM2 in Gastric Cancer Cells

Inhibiting PKCβ2 protects HK-2 cells against meglumine diatrizoate and AGEs-induced apoptosis and autophagy.

Identification of potential targets for diallyl disulfide in human gastric cancer MGC-803 cells using proteomics approaches.

Targeting the ROS/PI3K/AKT/HIF‐1α/HK2 Axis of Breast Cancer Cells: Combined Administration of Polydatin and 2‐Deoxy‐d‐glucose

Silencing PKM2 by Sirna Inhibits Proliferation and Glycolysis of Human Gastric Adenocarcinoma Cell Line SGC-7901

Diallyl disulfide antagonizes DJ‐1 mediated proliferation, epithelial–mesenchymal transition, and chemoresistance in gastric cancer cells

DADS Inhibits the Proliferation of MDCC-MSB-1 Cells by Inducing Autophagy via the MEK/ERK Signalling Pathway

Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination

Pyruvate Kinase M2 Contributes to Cell Growth in Gastric Cancer Via Aerobic Glycolysis.

CMPD1 Inhibited Human Gastric Cancer Cell Proliferation by Inducing Apoptosis and G2/M Cell Cycle Arrest

Diallyl disulfide enhances carbon ion beams-induced apoptotic cell death in cervical cancer cells through regulating Tap73 /ΔNp73.

Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells:

Dihydromyricetin Induces Cell Apoptosis Via A P53-Related Pathway in Ags Human Gastric Cancer Cells

Inhibition of ERK and activation of p38 are involved in diallyl disulfide induced apoptosis of leukemia HL-60 cells

MP51-06 SMYD3 INHIBITION INDUCES PROTECTIVE AUTOPHAGY IN BLADDER CANCER VIA MTOR PATHWAY

KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer

Study on Diallyi Disulfide Inhibiting the Proliferation of Human Small Cell Lung Cancer H446 Cells

Novel Specific Pyruvate Kinase M2 Inhibitor, Compound 3h, Induces Apoptosis and Autophagy through Suppressing Akt/mTOR Signaling Pathway in LNCaP Cells

Deoxypodophyllotoxin Inhibits Non-Small Cell Lung Cancer Cell Growth by Reducing HIF-1α-Mediated Glycolysis

3-Bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth

Efficacy and mechanism of combination of oxaliplatin with PKM2 knockdown in colorectal cancer